Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gamida Cell Ltd
(NQ:
GMDA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gamida Cell Ltd
< Previous
1
2
3
4
5
6
7
Next >
Gamida Cell to Present Corporate Highlights at 2022 Cell & Gene Meeting on the Mesa
October 10, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Flotek Industries, Clear Channel Outdoor And 2 Other Penny Stocks Insiders Are Aggressively Buying
October 05, 2022
The Dow Jones jumped by more than 800 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Long-Term Data from Omidubicel Phase 3 Trial Demonstrates Overall Survival and Sustainable Durable Outcomes for Patients with Blood Cancers at the Society of Hematologic Oncology Meeting
September 29, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Recap: Gamida Cell Q2 Earnings
August 15, 2022
Gamida Cell (NASDAQ:GMDA) reported its Q2 earnings results on Monday, August 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
September 29, 2022
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
September 28, 2022
It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.
Via
InvestorPlace
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
September 28, 2022
Gainers
Via
Benzinga
Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket
September 28, 2022
Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday.
Via
Benzinga
Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares
September 28, 2022
From
Gamida Cell
Via
Business Wire
Gamida Cell Announces Entry into Commitment Letter with Highbridge for $25 Million Financing
September 28, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces Launch of Public Offering of Ordinary Shares
September 27, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Appoints Abigail L. Jenkins as President and Chief Executive Officer, Bringing Broad Leadership Experience in Commercializing Innovative Therapies
September 19, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Presents Data Demonstrating the Impact of Transplantation with Omidubicel for Patients with Hematologic Malignancies at 2022 Cord Blood Connect Meeting
September 12, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Reports Second Quarter 2022 Financial Results and Provides Company Update
August 15, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces Dosing of First Patient in Company-Sponsored Phase 1/2 Study of NK Cell Therapy Candidate GDA-201
August 10, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces the Date of Its Second Quarter 2022 Financial Results and Webcast
August 08, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Earnings Scheduled For August 15, 2022
August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
Via
Benzinga
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
August 12, 2022
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results.
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 01, 2022
Via
Benzinga
FDA Accepts Gamida's Filing For Stem Cell Transplant Candidate Under Priority Review
August 01, 2022
The U.S. Food and Drug Administration (FDA) has accepted for filing the Gamida Cell’s (NASDAQ: GMDA) Biologics License Application (BLA) for omidubicel in the treatment of patients with blood cancers...
Via
Benzinga
Gamida Cell Announces FDA Acceptance of Biologics License Application for Omidubicel with Priority Review
August 01, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
July 22, 2022
During Friday's session, 61 companies made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
July 25, 2022
On Monday, 100 companies reached new 52-week lows.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 16, 2022
It's time for another breakdown of the biggest pre-market stock movers as we go over the latest news for Thursday morning.
Via
InvestorPlace
27 Stocks Moving in Thursday's Pre-Market Session
June 16, 2022
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) rose 92.9% to $3.28 in pre-market trading following’s Wednesday IPO.
Via
Benzinga
Gamida Cell to Present Corporate Highlights at the JMP Securities Life Sciences Conference
June 13, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Appoints Ivan M. Borrello, M.D., Expert in Immuno-Oncology, Cell Therapies, and Bone Marrow Transplant to Board of Directors
June 10, 2022
From
Gamida Cell
Via
Business Wire
Gamida Cell Completes Rolling Biologics License Application Submission to the FDA for Omidubicel
June 02, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference
June 01, 2022
From
Gamida Cell Ltd.
Via
Business Wire
Gamida Cell Announces Opening to Enrollment of Company-Sponsored Phase 1/2 Study of NK Cell Therapy Candidate GDA-201
June 01, 2022
From
Gamida Cell Ltd.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.